Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Brasil
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • PORTAL DE CLÍNICAS
  • Solicitar informação
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • Part of brands: |
Igenomix BrasilIgenomix Brasil
  • Part of brands: |
  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog
Home > Genetic Solutions

CGT: Carrier Genetic Test

CGT is an advanced carrier genetic test before pregnancy to determine the risk of having a chind with a genetic disease.

  • Technical overview
  • Disorders
  • Gamete banks
  • Documentation
  • Scientific evidence
  • Tools
  • I’m not a health specialist

The global prevalence of genetic diseases is 10 in 1000 newborn infants.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

84% of individuals are carriers of at least one condition.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

The average person is carrier of 2 disease-causing mutations.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Inherited disorders represent 20% of the causes of infant mortality in developed countries

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Request information

We answer in 48 hours lorem ipsum sis amet

Write us

Course CGT

Access the e-learning portal to attend the course

Order now
About CGT

What is a single gene disorder?

A single gene disorder it’s a hereditary disorder caused by the presence of a mutation, or mutations, in a particular gene. Gene disorders can’t be cured, but they can be prevented.

It identifies couples in which both partners are carriers. In this way it prevents serious genetic disorders in their offspring.

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy, Fragile-X Syndrome amongst others by NGS.

If both partners carry a mutation in the same gene, they will be at high risk of having an affected child. In these cases, there are options for conceiving healthy children, like Preimplantation Genetic Diagnosis or gamete donation. It’s also possible to use prenatal diagnosis after conceiving naturally.

Most carriers of genetic mutations don’t have a family history of these disorders

Test features

  • Study on more than 6,000 mutations associated with over 600 genetic disorders.
  • Genetic counseling for patients and specialists.
  • Availability of a specific module for gamete donation programs.
  • Genetic screening test based on massive sequencing (NGS) and clinically validated.

Who is this test for?

For any couple who wants to form a family to know the risk of transmitting hereditary disorders to their children

Before an assisted reproduction treatment

Before a treatment with donor sperm or eggs.

Which disorders are studied?

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy,
Fragile-X Syndrome amongst others.

CGT 600 Related publications

What’s the procedure?

The test requires 5 ml of blood collected in an EDTA tube which is transported at room temperatur and with the recommended protection: a padded envelope or in the pack sent in the kit. The sample should be sent within a maximum of 48 hours.

How is a carrier screening performed?

Doctor prescibes test
Blood sample
DN Aanlaysis by NGS
Mutation report

How do we interpret the results?

+ POSITIVE

If the tested person carries a mutation in a particular gene, the test should be carried out in the other member of the couple.

- NEGATIVE

A negative result indicates that the person doesn’t carry any of the mutations studied. There is still residual risk of carrying another mutation not analyzed by the test.

Application of the test to the donor bank

At Igenomix we offer the test to infertility clinic patients receiving a sperm or egg donation. The joint study of both the donor and recipient significantly reduces the possibility of having a baby affected by the disorders studied.

Why choose the Igenomix Carrier Screening Test?

39,000

TESTS PERFORMED

53

PARTNER CLINICS

14

LABS IN 9 COUNTRIES

How can I explain this service to my patients

Non-technical explanation for your patients Brochure for your patients Product sheet
Documentation & Resources

For printing or to download

FICHA

Download

FICHA

Download

FICHA

Download

Tools:

TOOLS

Calculator

Sociis natoque penatibus et magnis dis parturient montes.

Download
Scientific evidence

Relevant related studies:

Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Methodology
CGT for gamete banks

 Lorem ipsum dolor est

The Carrier Screening Test from Igenomix provides a powerful and exclusive computerized
tool called CGT Match. This software allows genetically matched gametes to be selected for a
recipient after analyzing the egg or sperm bank of an assisted reproduction clinic.

Difference between a genetically tesed banck and a non tested bank

1 / 20

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

TESTED

1 / 110,000

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

NON TESTED
Technical information

Test limitations

  • The sensitivity of the test is 98%.
  • We only analyze genes on the list available, reporting results based on knowledge current at the time of testing. Therefore, only genes included in this list will be detected.
  • The method is based on analysis by massive parallel sequencing and bioinformatics, studying all the exons of the genes included on our gene list. This includes adjacent intronic regions before or after position +5 and -5. Variants located outside the gene regions studied, such as gene-expression regulatory regions or intronic regions before or after position +5 and -5 are not detected.
  • No inversions, deletions, or duplications over 20 nucleotides long that are not referred to in the list available, are studied.
  • Germ mosaics (mutations only present in gametes) are not detected by this analysis because the DNA material studied is obtained from a blood sample.
  • A negative result for the genes indicated does not exclude the possibility that a de novo mutation may appear in the offspring.

Se você está um pouco perdido com esta informação técnica...

Podemos te ajudar?

Sou paciente

Igenomix e fertilidade

Trabalhamos para construir um mundo onde a infertilidade não é mais uma barreira impossível. Juntamente com clínicas e médicos de fertilidade em todo o mundo investigamos a reprodução humana para mudar a vida dos casais que estão tentando engravidar.

Saiba mais sobre a Igenomix
email

Receba a nossa newsletter

[gravityform id=1 title=false description=false ajax=true tabindex=49]

Acesse cursos

Cursos relacionados à genética e medicina reprodutiva

Lorem ipsum sis amet

Sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nam fermentum, nulla luctus pharetra vulputate, felis tellus mollis orci, sed rhoncus pronin sapien nunc accuan eget. More information

Lorem ipsum sis amet

Sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nam fermentum, nulla luctus pharetra vulputate, felis tellus mollis orci, sed rhoncus pronin sapien nunc accuan eget. More information

Quero saber mais sobre os testes genéticos


Igenomix related services

Proain agravida dolor sit amet lacus accumsan et viverra justo commodo

PGS

Preimplantation Genetic Screening

Early risk detection of hereditary breast and ovarian cancer

More information

Block "788" not found

NÓS TE GUIAMOS

Fertilidade
Prevenção de doenças hereditárias
Gravidez saudável

TODOS OS SERVIÇOS

Genética Reprodutiva
Diagnóstico de Doenças Genéticas

SOBRE NÓS

Sobre a Igenomix
Laboratórios
Notícias
Qualidade
Trabalhe conosco
Como enviar uma amostra?

gestão de resíduos

SIGA-NOS

Blog: Caminho da Fertilidade

SELO ONA 2026

⬇️ Clique e confira o Certificado: 385-007-279

Instituição Acreditadora Credenciada Instituto Qualisa de
Gestão - IQG | Validade: 10/2026

Central de Atendimento Brasil: 11 2500 1570 WhatsApp: 11 9 7117 9759  atendimentoaocliente@igenomix.com

  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Idioma

Igenomix Brasil Laboratório de Medicina Genética LTDA |
CNPJ 19.555.576/0001-43 | Endereço Av. República do Líbano, 500 - 04502-000 | São Paulo - SP | Responsável Técnica: Paula Regina Queiroz Estrada CRbio 113829/01-D | email: infobrasil@igenomix.com

[2024] © Igenomix Política de qualidade Política de Privacidade  Nota legal Política de cookies Direitos do Paciente

Contato



  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog
  • Brasil
  • PORTAL DE CLÍNICAS
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759